Overview
Rabies is a fatal viral zoonotic disease caused by lyssaviruses, most commonly the rabies virus (RABV), belonging to the family Rhabdoviridae. The disease is transmitted to humans primarily through the bite or scratch of an infected animal, most often dogs, bats, raccoons, skunks, and foxes. The virus enters peripheral nerves at the wound site and travels to the central nervous system, where it causes progressive and almost invariably fatal encephalomyelitis. Rabies is classified under Orphanet code 770 and ICD-10 codes A82.0 (sylvatic rabies), A82.1 (urban rabies), and A82.9 (rabies, unspecified). The incubation period is highly variable, typically ranging from one to three months but can extend from days to over a year, depending on the site and severity of the bite and the viral load. The disease presents in two clinical forms: furious (encephalitic) rabies, which is more common and characterized by hyperactivity, hydrophobia (fear of water), aerophobia (fear of drafts), agitation, confusion, hallucinations, and autonomic dysfunction; and paralytic (dumb) rabies, which presents with ascending paralysis resembling Guillain-Barré syndrome. Both forms progress to coma and death, typically within days to weeks of symptom onset. Hydrophobia, caused by painful spasms of the pharyngeal and diaphragmatic muscles triggered by attempts to swallow, is considered pathognomonic for rabies. Once clinical symptoms appear, rabies is almost universally fatal, with only a handful of documented survivors worldwide. However, rabies is entirely preventable through timely post-exposure prophylaxis (PEP), which includes thorough wound washing, administration of rabies immunoglobulin, and a series of rabies vaccine doses. Pre-exposure prophylaxis vaccination is recommended for individuals at high risk, such as veterinarians, animal handlers, and travelers to endemic regions. Despite the availability of effective prevention, rabies causes an estimated 59,000 human deaths annually worldwide, predominantly in Asia and Africa, with most cases resulting from dog bites in resource-limited settings where access to PEP is inadequate.
Clinical phenotype terms— hover any for plain English:
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
10 eventsInstitute of Tropical Medicine, Belgium — PHASE3
Changchun BCHT Biotechnology Co. — PHASE3
Sinovac Biotech Co., Ltd — PHASE3
Sinovac Biotech Co., Ltd — PHASE3
Sinovac Biotech Co., Ltd — PHASE3
Ab&B Bio-tech Co., Ltd.JS — PHASE3
Lanzhou Institute of Biological Products Co., Ltd — PHASE2
International Centre for Diarrhoeal Disease Research, Bangladesh — PHASE2, PHASE3
University of Oxford — PHASE2
Changchun BCHT Biotechnology Co. — PHASE1
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Rabies.
7 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Rabies.
Community
No community posts yet. Be the first to share your experience with Rabies.
Start the conversation →Latest news about Rabies
Disease timeline:
New recruiting trial: A Clinical Trial of Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried
A new clinical trial is recruiting patients for Rabies
New recruiting trial: Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations
A new clinical trial is recruiting patients for Rabies
New recruiting trial: A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults
A new clinical trial is recruiting patients for Rabies
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Rabies
What is Rabies?
Rabies is a fatal viral zoonotic disease caused by lyssaviruses, most commonly the rabies virus (RABV), belonging to the family Rhabdoviridae. The disease is transmitted to humans primarily through the bite or scratch of an infected animal, most often dogs, bats, raccoons, skunks, and foxes. The virus enters peripheral nerves at the wound site and travels to the central nervous system, where it causes progressive and almost invariably fatal encephalomyelitis. Rabies is classified under Orphanet code 770 and ICD-10 codes A82.0 (sylvatic rabies), A82.1 (urban rabies), and A82.9 (rabies, unspecif
Are there clinical trials for Rabies?
Yes — 7 recruiting clinical trials are currently listed for Rabies on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Rabies?
25 specialists and care centers treating Rabies are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.